mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
Tiago Azenha Rama, André Moreira, Mariana Castells
The Journal of allergy and clinical immunology